Skip to main
AOD-9604 Store

A plain-spoken research digest of AOD-9604 — the growth-hormone fat-loss fragment, read straight from the trials, including the human one that came up empty.

When the scale still will not move

AOD-9604 Weight Loss: the result in people

Mice lost fat. Adults in the main test lost no extra weight.

What is the short answer?

A stubborn scale can make any claim sound hopeful. AOD-9604 did not beat placebo in people.

The main human test found no extra drop on the scale. Around 2007, the company ended its weight program after that result [9] [10].

Animal results explain the sales pitch that remains. Obese mice became lighter and carried less body fat [1] [2].

A mouse result is an early clue. It isn't the answer for a person.

About 900 overweight adults supplied that answer [5] [9]. Their results did not match the mice.

The studies below keep animals and people apart. You can weigh both results with clear labels.

A large test in adults comes closest to your own concern about the scale. That test found no useful weight loss.

What changed in the mice?

Researchers treated obese mice with AOD-9604 for 14 days [1]. The mice lost body weight and fat.

The treated mouse fat cells held more beta-3, a protein that helps burn fuel. Lean mice already had more of that protein.

A second study also found weight loss in obese mice [2]. Those mice burned more fat during long treatment.

Another test found that cells built less new fat [4]. That change happened inside cells in a dish.

The mice made less fat and burned more. The subjects were still mice, not people.

Those animal findings gave researchers a sound reason to begin human testing. They gave no promise for your weight.

What changed in the mice?

What changed in the adults?

About six human tests included roughly 900 obese adults [5]. Some got tablets, while others got placebo.

Tablet amounts ranged from 0.25 mg to 54 mg. The tests lasted from 7 days to 24 weeks.

Side effects were hard to tell apart. That short-term safety finding was useful.

The main test asked about weight loss. AOD-9604 didn't beat placebo [9] [10].

The AOD-9604 weight program then ended. The drug gained no approval for any use [9].

Later reviews record the same failed result [8] [10]. A good mouse idea wasn't enough.

The adults supplied the result many sales pages omit. Their scale change matched the placebo group.

Which sales claims go too far?

One claim calls the drug a “fat burner.” Early animal papers mainly found that cells made less new fat [3] [4].

Animals and cells supplied that finding; people did not. The work showed no human body fat melting away.

Another claim promises fat loss near a shot. No human test supports loss in one chosen spot.

Bodies don't choose one fat patch by shot location. That sales claim has no sound support.

A third claim gives the drug credit for every change. People often changed food and training at the same time.

Those changes can move weight by themselves. Human tests are the closest match for your own expectations.

A sales claim may borrow from real mouse work. The trouble begins when a mouse result becomes a promise for people.